Who we are

Adjuvatis develops, manufactures biocompatible delivery system called i-Particles® and proposes a formulation service based on its technology.

Our Mission

Providing scientists and pharmaceutical companies safer, more stable and effective formulations thanks to i-Particles® technology.

Our Advisory Board

Adjuvatis team is built around valuable experts, gathering insights into scientific orientations, business development and customer-dedicated marketing strategy.

Our Network

From extending our technological network to supporting innovation, Adjuvatis scientific partners widen our panel of expertise and contribute to strive for excellence.


Fully metabolizable i-Particles

i-Particles® technology originates from the fundamental statement that pharmaceuticals should never involve harmful by-products and only focus on patient safety. Starting from this idea, Adjuvatis technology is led by one main concept: safe-by-design.

i-Particles Technology

Synthetized by an eco-friendly and additive-free process, i-Particles® exclusively consist in a biodegradable polymer and selected active pharmaceutical ingredients.

Strategic solutions

Increasing pharmaceutical efficacy and safety while reducing risk profile and costs, and extending product life cycle.


Following 10 years of research and supported by a multi-skilled team, Adjuvatis will push forward your active’s intrinsic properties and potentiate your product development.


i-Particles - Driver of innovation

i-Particles® formulations have demonstrated enhancements in healthcare and technological fields, especially vaccines, antibody generation and drug delivery. Adjuvatis is constantly extending the scope of applications to reach new markets, support customer developments and prove once again the versatility of its technology.


Vaccine Development

i-Particles® increase immunogenicity and improve stability of vaccines formulations.


Antibody Generation

Reduce antibodies production costs and improve their affinity using i-Particles®.


Drug Delivery System

Formulating with i-Particles® offer protection and sustained delivery for your active pharmaceutical ingredient.


i-Particles-based formulations & in-depth characterizations

Adjuvatis provides a full formulation development and characterization services in a rigorous quality framework.


What are you waiting for?

Discover our fully dedicated and quality-oriented ways of working, integrating both skills and experience to provide cutting-edge service for formulation development of biopharmaceuticals.


Meet Our Team

Our dynamic team, supported by a referent advisory board and external experts, qualifies for expertise in Chemistry, Biochemistry and Biology, Manufacturing and Partnering. By working collaboratively, we are committed to innovate for your therapeutic products developments.


Why formulate with adjuvatis?

Overcome technical obstacles and reach new markets.


Expertise optimise us

Feel free to contact us to explore licensing opportunities, collaborative researches, or commercial partnerships.


Adjuvatis Live

Follow our participation to scientific events, symposium and congresses.
Discover our press releases and publications.

Funding awarded for an Innovative Training Network, DRIVE!

  • By maria
  • on Déc 04, 2017
Adjuvatis is hiring a PhD Student for 3 years starting at May 2018 The European Innovative Training Network DRIVE (Driving.
Read More

Groupement de Recherche Cosm’actifs – GDR 3711

  • By maria
  • on Déc 04, 2017
Adjuvatis is invited to present the results of researches conducted on drug delivery in the skin by using the i-Particles.
Read More

11ème édition des Journées Collaboratives

  • By maria
  • on Déc 04, 2017
Adjuvatis is going to the Partnering Days organized by the Bio Cluster Lyonbiopole to participate in brainstorming sessions and to.
Read More

Welcome in Lyon

At the heart of the Biodistrict Lyon Gerland, a hotspot for world leaders in Life Sciences in vicinity to institutional, academic and private companies, Adjuvatis benefits from a unique environment in terms of technological innovation.